People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vitro Biopharma, Inc. | — | Biotechnology | Seed | $7.1M | $293K | 2023 |
Christopher Furman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Furman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Evans | 1 | 4 |
| Jack Zamora | 1 | 2 |
| Thomas Ohrt | 1 | 1 |
| Chris Furman | 1 | 1 |
| Caroline Mosessian | 1 | 1 |
| Tiana R States | 1 | 1 |
| John Packs | 1 | 1 |
| John R Packs | 1 | 1 |
| James R Musick | 1 | 1 |
| Caroline R Mosessian | 1 | 1 |
| Nathan Haas | 1 | 1 |
| James Musick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.